Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment
Sign Up to like & getrecommendations! Published in 2023 at "Science Advances"
DOI: 10.1126/sciadv.abq3104
Abstract: Therapeutic antibodies are extensively used to treat fundus diseases by intravitreal injection, as eyedrop formulation has been rather challenging due to the presence of ocular barriers. Here, an innovative penetrating carrier was developed for antibody… read more here.
Keywords: fundus; based macromolecular; treatment; eyedrop based ... See more keywords